Streetbeat News

Stock Prices

GILD

The article provides a comparative analysis of Gilead Sciences (NASDAQ:GILD) and its competitors in the Biotechnology industry. The analysis reveals that Gilead Sciences may be undervalued as it has low PE, PB, and PS ratios compared to its peers. However, the company has high ROE, EBITDA, gross profit, and revenue growth, indicating strong financial performance and potential for future growth.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 4:02 pm

NBN

Northeast Bank (NASDAQ:NBN) is set to release its latest quarterly earnings report on October 23, 2023. Analysts estimate an earnings per share (EPS) of $1.56. The bank's past performance shows a trend of beating EPS estimates, which has generally led to an increase in share price. The bank's shares were trading at $44.8 as of October 19, with a 52-week increase of 8.51%.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 4:01 pm

TDOC

In the last quarter, Teladoc Health (NYSE:TDOC) received 1 somewhat bullish and 5 indifferent analyst ratings. Over the past 3 months, 6 analysts have offered 12-month price targets for Teladoc Health, with an average price target of $28.0, a decrease of 6.67% from the previous average price target of $30.00.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 4:01 pm

HSTM

HealthStream (NASDAQ:HSTM) is set to release its latest quarterly earnings report on Monday, 2023-10-23. Analysts estimate an earnings per share (EPS) of $0.09. Last quarter, the company beat EPS by $0.04, which was followed by a 1.21% drop in the share price the next day. Shares of HealthStream were trading at $22.34 as of October 19, with a 52-week increase of 2.99%.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 4:01 pm

EQT

Over the past 3 months, 13 analysts have published their opinion on EQT (NYSE:EQT) stock. The average price target for EQT is $42.23, a decrease of 0.4% from the previous average price target of $42.40. The ratings include 1 bullish, 5 somewhat bullish, 6 indifferent, and 1 somewhat bearish.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 4:01 pm

IBTX

Independent Bank Gr (NASDAQ:IBTX) is set to release its latest quarterly earnings report on October 23, 2023. Analysts estimate an earnings per share (EPS) of $0.73. The company's past performance shows a trend of missing EPS estimates and subsequent drops in share price. The stock is currently trading at $37.26, down 43.63% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 4:01 pm

KREF

KKR Real Estate Finance (NYSE:KREF) is set to release its latest quarterly earnings report on October 23, 2023. Analysts estimate an earnings per share (EPS) of $0.22. The company's past performance shows a trend of beating EPS estimates but experiencing a drop in share price the following day. The stock is currently trading at $10.56, down 38.14% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 4:01 pm

HUM

Humana's (NYSE:HUM) short percent of float has risen 4.21% since its last report, with 2.75 million shares sold short, which is 2.23% of all regular shares available for trading. It would take traders 2.79 days to cover their short positions on average. An increase in short interest can signal that investors have become more bearish. However, Humana's peer group average for short interest as a percentage of float is 3.07%, which means the company has less short interest than most of its peers.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 4:01 pm

ORCL

Oracle's shares are trading lower after the company's AI Executive Forum event.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 4:01 pm

CRGY

Crescent Energy (NYSE:CRGY) has received positive ratings from analysts in the last quarter, with 5 bullish and 2 somewhat bullish ratings. The average 12-month price target for the company is $18.43, which has increased by 4.3% over the past month.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 4:01 pm